Drugplain

UZEDY 125 mg/.35mL

risperidone · INJECTION, SUSPENSION, EXTENDED RELEASE · Teva Pharmaceuticals USA, Inc.

No Recall History
Plain English

UZEDY is a injection, suspension, extended release containing risperidone at 125 mg/.35mL, taken subcutaneous. Manufactured by Teva Pharmaceuticals USA, Inc..

Key Facts

Brand Name
UZEDY
Generic Name
risperidone
NDC Code (Product)
51759-630
Manufacturer
Teva Pharmaceuticals USA, Inc.
Strength
125 mg/.35mL
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
SUBCUTANEOUS
Marketing Status
Application #
NDA213586
Drug Class
Atypical Antipsychotic [EPC]
Marketing Start
05/01/2023

Recall History

No Recall History

Frequently Asked Questions

What is UZEDY used for?

UZEDY contains risperidone. It is a injection, suspension, extended release taken subcutaneous. Consult your doctor for specific uses.

Is UZEDY a controlled substance?

UZEDY is not classified as a controlled substance by the DEA.

What is the generic name for UZEDY?

The generic name for UZEDY is risperidone. There are 12 other brand versions of risperidone.

What is the NDC code for UZEDY 125 mg/.35mL?

The NDC (National Drug Code) for UZEDY 125 mg/.35mL is 51759-630, listed by Teva Pharmaceuticals USA, Inc..

Product NDC

51759-630

Package NDC

51759-630-10

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)